Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim PharmafiledCriticalBoehringer Ingelheim Pharma
Publication of ECSP034921ApublicationCriticalpatent/ECSP034921A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
La invención se relaciona con cristalino, libre de agua (1a, 2b, 4b, 5a, 7b) - [(hidroxidi-2-tienilacetil)oxi]-9, 9-dimetil-3-oxa-9-azoniatriciclo[3.3.1.02,4]nonana-bromuro, a un método para su producción, y para el uso del mismo en la producción de una droga, especialmente en la producción de una droga anticolinérgicaThe invention relates to crystalline, water-free (1a, 2b, 4b, 5a, 7b) - [(hydroxidi-2-thienylacetyl) oxy] -9,9-dimethyl-3-oxa-9-azoniatricyclo [3.3.1.02 , 4] nonana-bromide, to a method for its production, and for the use thereof in the production of a drug, especially in the production of an anticholinergic drug
ECSP0349212001-06-222003-12-22
CRYSTALLINE ANTI-POLYNERGIC, METHOD FOR PRODUCTION, AND USE OF THE SAME IN THE PRODUCTION OF A DRUG
ECSP034921A
(en)
Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).
Nociceptin derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of pain (sol. divisional 2103-03).
Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).